Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 7, 2009, Pages 1288-1297

  Einenkel, Jens ^a   Ott, Rudolf ^a   Handzel, Romy ^a   Braumann, Ulf Dietrich ^a   Horn, Lars Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Diaphragm; Ovarian carcinoma; Surgery

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAPHRAGM DISEASE; DIAPHRAGM RESECTION; FEMALE; HEMIDIAPHRAGM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MORBIDITY; OVARY CANCER; PERITONEUM CANCER; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THORAX SURGERY; UTERINE TUBE CARCINOMA; CANCER STAGING; CARCINOMA; COMORBIDITY; DIAPHRAGM; DISEASE COURSE; EVALUATION; GYNECOLOGIC SURGERY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MUSCLE TUMOR; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PREVALENCE; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; UTERINE TUBE TUMOR; UTILIZATION REVIEW;

ADULT; AGED; CARCINOMA; COMORBIDITY; DIAPHRAGM; DISEASE PROGRESSION; FALLOPIAN TUBE NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 73449132974     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a3a833     Document Type: Article

References (35)

1. Aletti GD, Dowdy SC, Podratz KC, et al. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol. 2006;100: 283-287.
2. Thigpen T. The if and when of surgical debulking for ovarian carcinoma. N Engl J Med. 2004;351:2544-2546.
3. Markman M. Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action. J Clin Oncol. 2007;25:4168-4170.
4. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with Bbiological aggressiveness[ and survival? Gynecol Oncol. 2001;82: 435-441.
5. Benedet JL, Bender H, Jones H 3rd, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209-262.
6. Gershenson DM. Primary cytoreduction for advanced epithelial ovarian cancer. Obstet Gynecol Clin North Am. 1994;21:121-140.
7. Eisenkop SM, Spirtos NM, Lin WC. "Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary. Gynecol Oncol. 2006;103:329-335.
8. Chassagne D, Sismondi P, Horiot JC, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol. 1993;26:195-202.
9. Lee KR, Tavassoli FA, Prat J, et al. Tumours of the ovary and peritoneum. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 113-202.
10. Bookwalter JR. A new table-fixed retractor. Surg Clin North Am. 1980;60:399-405.
11. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol. 1989;35:338-340.
12. Eisenhauer EL, Chi DS. Liver mobilization and diaphragm peritonectomy/resection. Gynecol Oncol. 2007;104:25-28.
13. Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol. 2006;103: 871-877.
14. Fiorica JV, Hoffman MS, LaPolla JP, et al. The management of diaphragmatic lesions in ovarian carcinoma. Obstet Gynecol. 1989;74:927-929.
15. Goff BA, Matthews BJ, Wynn M, et al. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol. 2006;103: 383-390.
16. Eisenkop SM, Spirtos NM. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol. 2001;82:489-497.
17. Deppe G, Malviya VK, Boike G, et al. Use of Cavitron surgical aspirator for debulking of diaphragmatic metastases in patients with advanced carcinoma of the ovaries. Surg Gynecol Obstet. 1989;168: 455-456.
18. Scholz HS, Tasdemir H, Hunlich T, et al. Multivisceral cytoreductive surgery in FIGO stages IIIC and IVepithelial ovarian cancer: results and 5-year follow-up. Gynecol Oncol. 2007;106:591-595.
19. Devolder K, Amant F, Neven P, et al. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer. 2008;18: 363-368.
20. Aletti GD, Dowdy SC, Gostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107:77-85.
21. Eisenkop SM, Spirtos NM, Lin WC. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer. Gynecol Oncol. 2006;100:344-348.
22. Rosenoff SH, Young RC, Chabner B, et al. Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinoma. Natl Cancer Inst Monogr. 1975;42:81-86.
23. Hacker NF, Berek JS, Lagasse LD, et al. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 1983;61:413-420.
24. Deppe G, Malviya VK, Boike G, et al. Surgical approach to diaphragmatic metastases from ovarian cancer. Gynecol Oncol. 1986;24:258-260.
25. Kapnick SJ, Griffiths CT, Finkler NJ. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol Oncol. 1990;39:135-138.
26. Silver DF. Full-thickness diaphragmatic resection with simple and secure closure to accomplish complete cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol. 2004;95:384-387.
27. Cliby W, Dowdy S, Feitoza SS, et al. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol. 2004;94:655-660.
28. Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7:925-934.
29. Eisenkop SM. Thoracoscopy for the management of advanced epithelial ovarian cancer-a preliminary report. Gynecol Oncol. 2002;84: 315-320.
30. Juretzka MM, Abu-Rustum NR, Sonoda Y, et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol. 2007;104:670-674.
31. Juretzka MM, Horton FR, Abu-Rustum NR, et al. Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature. Gynecol Oncol. 2006;100:618-620.
32. Dos Santos LA, Modica I, Flores RM, et al. En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report. Gynecol Oncol. 2006;102:596-598.
33. Gilani MM, Karimi Zarchi M, Ghaemmaghami F, et al. A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer. Gynecol Oncol. 2007;105:780-783.
34. Aletti GD, Dowdy S, Podratz KC, et al. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006;195:1862-1868.
35. Farias-Eisner R, Teng F, Oliveira M, et al. The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery. Gynecol Oncol. 1994;55:108-110.